Sabby Management, LLC Contrafect Corp Transaction History

Sabby Management, LLC

  • $1.52 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.79 - $4.45 $262,315 - $418,389
-94,020 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$2.26 - $3.84 $220,700 - $374,995
-97,655 Reduced 50.95%
94,020 $343,000
Q4 2021

Feb 14, 2022
BUY
$2.47 - $4.14 $62,985 - $105,569
25,500 Added 15.35%
191,675 $504,000
Q1 2021

May 17, 2021
BUY
$4.46 - $6.68 $741,140 - $1.11 Million
166,175 New
166,175 $798,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email